|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/16 | |
| A61K 31/4035 | |||
| A61P 31/14 |
| (11) | Number of the document | 2637643 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11779654.0 |
| Date of filing the European patent application | 2011-11-07 | |
| (97) | Date of publication of the European application | 2013-09-18 |
| (45) | Date of publication and mention of the grant of the patent | 2014-12-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/069492 |
| Date | 2011-11-07 |
| (87) | Number | WO 2012/062685 |
| Date | 2012-05-18 |
| (30) | Number | Date | Country code |
| 10190461 | 2010-11-09 | EP |
| (72) |
LEIMINER, Andreas, DE
LINDENSTRUTH, Kai, DE
MILLER, Dave Alan, US
SCHEUBEL, Emmanuel, FR
SHAH, Navnit Hargovindas, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | PHARMACEUTICAL COMPOSITION FOR TREATING HCV INFECTIONS |
| PHARMACEUTICAL COMPOSITION FOR TREATING HCV INFECTIONS |